Reduction seen in odds of major depressive episode, moderate-to-severe anxiety with intervention sessions delivered by nonspecialist
Hair cortisol concentrations, but not composite stress, anxiety, and depression scores, predicted birth complications
Findings seen for amphetamine/dextroamphetamine and methylphenidate exposure
Exposure during pregnancy, especially during the second trimester, is linked to later problems
Buprenorphine associated with lower risk for malformations, cardiac malformations, oral clefts, and clubfoot
Bidirectional association more pronounced among women without psychiatric comorbidities, strongest for multiple sclerosis
Risk highest during the first year after diagnosis and for deaths due to suicide
Women in second and third versus first tertile of psychological stress have higher probabilities of having abnormal glucose during pregnancy
Increased risk seen in association with benzodiazepines ranging from odds ratios of 1.39 to 2.52 for alprazolam and fludiazepam
More than four in 10 had elevated scores on depression, anxiety, and/or stress